

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies. Among its major competitors, Vical is ranked in 6th place for NPS while Ultragenyx Pharmaceutical is 1st, and Illumina is 2nd.Their current market cap is $15.44M